Constitutive histamine H2 receptor activity regulates serotonin release in the substantia nigra
Article first published online: 29 AUG 2008
© 2008 The Authors. Journal Compilation © 2008 International Society for Neurochemistry
Journal of Neurochemistry
Volume 107, Issue 3, pages 745–755, November 2008
How to Cite
Threlfell, S., Exley, R., Cragg, S. J. and Greenfield, S. A. (2008), Constitutive histamine H2 receptor activity regulates serotonin release in the substantia nigra. Journal of Neurochemistry, 107: 745–755. doi: 10.1111/j.1471-4159.2008.05646.x
- Issue published online: 14 OCT 2008
- Article first published online: 29 AUG 2008
- Received March 3, 2008; revised manuscript received June 22, 2008; accepted August 15, 2008.
- basal ganglia;
- fast-scan cyclic voltammetry;
- Parkinson’s disease;
- substantia nigra pars reticulata
The substantia nigra pars reticulata (SNr) forms a principal output from the basal ganglia. It also receives significant histamine (HA) input from the tuberomammillary nucleus whose functions in SNr remain poorly understood. One identified role is the regulation of serotonin (5-HT) neurotransmission via the HA-H3 receptor. Here we have explored regulation by another HA receptor expressed in SNr, the H2-receptor (H2R), by monitoring electrically evoked 5-HT release with fast-scan cyclic voltammetry at carbon-fiber microelectrodes in SNr in rat brain slices. Selective H2R antagonists (inverse agonists) ranitidine and tiotidine enhanced 5-HT release while the agonist amthamine suppressed release. The ‘neutral’ competitive antagonist burimamide alone was without effect but prevented ranitidine actions indicating that inverse agonist effects result from constitutive H2R activity independent of HA tone. H2R control of 5-HT release was most apparent (from inverse agonist effects) at lower frequencies of depolarization (≤ 20 Hz), and prevailed in the presence of antagonists of GABA, glutamate or H3-HA receptors. These data reveal that H2Rs in SNr are constitutively active and inhibit 5-HT release through H2Rs on 5-HT axons. These data may have therapeutic implications for Parkinson’s disease, when SNr HA levels increase, and for neuropsychiatric disorders in which 5-HT is pivotal.